123 related articles for article (PubMed ID: 17874182)
41. Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer.
Generali D; Fox SB; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield SM; Bruzzi P; Bersiga A; Allevi G; Milani M; Aguggini S; Dogliotti L; Bottini A; Harris AL
Endocr Relat Cancer; 2006 Sep; 13(3):921-30. PubMed ID: 16954440
[TBL] [Abstract][Full Text] [Related]
42. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.
Harbeck N; Nimmrich I; Hartmann A; Ross JS; Cufer T; Grützmann R; Kristiansen G; Paradiso A; Hartmann O; Margossian A; Martens J; Schwope I; Lukas A; Müller V; Milde-Langosch K; Nährig J; Foekens J; Maier S; Schmitt M; Lesche R
J Clin Oncol; 2008 Nov; 26(31):5036-42. PubMed ID: 18711169
[TBL] [Abstract][Full Text] [Related]
43. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
44. Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial.
Knoop AS; Lænkholm AV; Jensen MB; Nielsen KV; Andersen J; Nielsen D; Ejlertsen B;
Eur J Cancer; 2014 May; 50(8):1412-21. PubMed ID: 24675287
[TBL] [Abstract][Full Text] [Related]
45. A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients.
Miglietta L; Morabito F; Provinciali N; Canobbio L; Meszaros P; Naso C; Murialdo R; Boitano M; Salvi S; Ferrarini M
Eur J Surg Oncol; 2013 Oct; 39(10):1046-52. PubMed ID: 23890870
[TBL] [Abstract][Full Text] [Related]
46. Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy.
Rahko E; Jukkola A; Melkko J; Paavo P; Bloigu R; Talvensaari-Mattila A; Turpeenniemi-Hujanen T
Anticancer Res; 2004; 24(6):4247-53. PubMed ID: 15736480
[TBL] [Abstract][Full Text] [Related]
47. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
48. Long-term pattern of disease recurrence among patients with early-stage breast cancer according to estrogen receptor status and use of adjuvant tamoxifen.
Khoshnoud MR; Fornander T; Johansson H; Rutqvist LE
Breast Cancer Res Treat; 2008 Jan; 107(1):71-8. PubMed ID: 18043896
[TBL] [Abstract][Full Text] [Related]
49. Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy.
Lin CH; Lien HC; Hu FC; Lu YS; Kuo SH; Wu LC; You SL; Cheng AL; Chang KJ; Huang CS
J Zhejiang Univ Sci B; 2010 Jan; 11(1):1-9. PubMed ID: 20043345
[TBL] [Abstract][Full Text] [Related]
50. Clinical significance of nuclear expression of spleen tyrosine kinase (Syk) in gastric cancer.
Nakashima H; Natsugoe S; Ishigami S; Okumura H; Matsumoto M; Hokita S; Aikou T
Cancer Lett; 2006 May; 236(1):89-94. PubMed ID: 15993535
[TBL] [Abstract][Full Text] [Related]
51. STMN1 in colon cancer: expression and prognosis in Chinese patients.
Zhang HQ; Guo X; Guo SQ; Wang Q; Chen XQ; Li XN; Guo LS
Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2038-44. PubMed ID: 27249602
[TBL] [Abstract][Full Text] [Related]
52. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
Zhao C; Li H; Wang L; Sun W
Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
[TBL] [Abstract][Full Text] [Related]
53. The prognostic role of a phospho-Stathmin 1 signature in breast cancer treated with neoadjuvant chemotherapy.
Xie Z; Zhen T; Lin Y; Shao N; Kuang X
Gland Surg; 2022 Nov; 11(11):1808-1816. PubMed ID: 36518803
[TBL] [Abstract][Full Text] [Related]
54. Expression of Syk in invasive breast cancer: correlation to proliferation and invasiveness.
Repana K; Papazisis K; Foukas P; Valeri R; Kortsaris A; Deligiorgi E; Kyriakidis D
Anticancer Res; 2006; 26(6C):4949-54. PubMed ID: 17214368
[TBL] [Abstract][Full Text] [Related]
55. A cohort study of STMN1 expression in colorectal cancer: body mass index and prognosis.
Ogino S; Nosho K; Baba Y; Kure S; Shima K; Irahara N; Toyoda S; Chen L; Kirkner GJ; Wolpin BM; Chan AT; Giovannucci EL; Fuchs CS
Am J Gastroenterol; 2009 Aug; 104(8):2047-56. PubMed ID: 19513025
[TBL] [Abstract][Full Text] [Related]
56. Targeted proteomics driven verification of biomarker candidates associated with breast cancer aggressiveness.
Procházková I; Lenčo J; Fučíková A; Dresler J; Čápková L; Hrstka R; Nenutil R; Bouchal P
Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):488-498. PubMed ID: 28216224
[TBL] [Abstract][Full Text] [Related]
57. High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.
Coebergh van den Braak RRJ; Sieuwerts AM; Kandimalla R; Lalmahomed ZS; Bril SI; van Galen A; Smid M; Biermann K; van Krieken JHJM; Kloosterman WP; Foekens JA; Goel A; Martens JWM; IJzermans JNM;
PLoS One; 2017; 12(9):e0185607. PubMed ID: 28957395
[TBL] [Abstract][Full Text] [Related]
58. Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma.
Bo X; Wang J; Fu Q; Wang Y; Liu H; Xu J
Oncotarget; 2017 Dec; 8(65):108548-108555. PubMed ID: 29312550
[TBL] [Abstract][Full Text] [Related]
59. The prognostic value and therapeutic target role of stathmin-1 in urinary bladder cancer.
Hemdan T; Lindén M; Lind SB; Namuduri AV; Sjöstedt E; de Ståhl TD; Asplund A; Malmström PU; Segersten U
Br J Cancer; 2014 Sep; 111(6):1180-7. PubMed ID: 25072257
[TBL] [Abstract][Full Text] [Related]
60. SIAH2 protein expression in breast cancer is inversely related with ER status and outcome to tamoxifen therapy.
van der Willik KD; Timmermans MM; van Deurzen CH; Look MP; Reijm EA; van Zundert WJ; Foekens R; Trapman-Jansen AM; den Bakker MA; Westenend PJ; Martens JW; Berns EM; Jansen MP
Am J Cancer Res; 2016; 6(2):270-84. PubMed ID: 27186402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
